Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 3 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Vanda Pharmaceuticals Inc. have a median target of 9.25, with a high estimate of 18.00 and a low estimate of 5.21. The median estimate represents a 87.25% increase from the last price of 4.94.
High | 264.4% | 18.00 |
Med | 87.2% | 9.25 |
Low | 5.5% | 5.21 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 05, 2025.
Average growth rate | -12.50% |
Average growth rate | -46.67% |
More ▼
Revenue history & estimates in USD
Average growth rate | +5.52% |
Average growth rate | -3.02% |
More ▼